The Publication Digests section is dedicated to providing concise reviews of recently published,
peer-reviewed literature relevant to the field of hereditary ATTR amyloidosis, which you can access below.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Developed by EPG Health for Medthority.com, with all content provided by Alnylam Pharmaceuticals. This section of the Learning Zone is sponsored and funded by Alnylam Pharmaceuticals. Please note that this material is intended for healthcare professionals only.
Date of preparation: February 2021 │ TTR02-CEMEA-00437│ TTR02-UK-00012.
Additional resources are available at www.hattramyloidosis.co.uk
© Copyright 2021